Funding for Luxturna following MSAC recommendation
Luxturna has become the first gene therapy to receive government funding in Australia, in a landmark decision that will see ...
Tag: retinitis pigmentosa
NHMRC grants recognise commercial potential of two vision-related innovations
Two vision-related innovations currently in development have received a significant financial boost as part of the Federal Government’s $15 million ...
Rewriting eye disease: Are we ready for gene therapies?
In 2020, ophthalmology became the first medical field in Australia to secure approval for a gene therapy. The one-off treatment ...
Funding for electroretinogram machine could halve waiting time
Funds raised from a campaign commencing in Queensland today will help purchase an additional electroretinogram machine that allows ophthalmologists to ...
Bringing Usher syndrome into focus
Usherkids Australia's new webinar series focuses on the latest research and clinical guidelines. Emily Shepard and Hollie Feller discuss collaborating ...
Charity donates $160K for inherited retinal disease research
Retina Australia has awarded a total of $160,000 in study grants to some of the biggest names in Australian retinal ...
Race to identify inherited retinal disease patients for gene therapies
Australian researchers are using genetic testing to identify as many people as possible with inherited retinal disease (IRD), in preparation ...
Supporting families with Usher syndrome
When a child is diagnosed with Usher syndrome, families can be left feeling overwhelmed and alone. EMILY SHEPARD and HOLLIE ...
New eye models allow for better drug development
A newly detailed model for cultivating retinal pigment cells could make the development of new and improved ocular drugs significantly ...
Genetic mutation responsible for Bardet-Biedl found
In a development that could lead to new treatments for the condition, a genetic mutation responsible for Bardet-Biedl Syndrome (BBS) ...